Skip to search formSkip to main contentSkip to account menu

alfuzosin

Known as: Alfuzosinum, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide 
A synthetic quinazoline compound with smooth muscle relaxing activity. Alfuzosin selectively binds to and antagonizes alpha-1-adrenergic receptors in… 
National Institutes of Health

Related topics

Related topics

9 relations
24 HR Alfuzosin hydrochloride 10 MG Extended Release Oral Tablet24 HR Alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral]Adrenergic alpha-Antagonists [MoA]Adrenergic alpha1-Antagonists [MoA]

Broader (3)

Adrenergic alpha-1 Receptor AntagonistsQuinazolinesUrological Agents

Narrower (1)

UroXatral

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived…
2009
2009
Effect of alfuzosin on female primary bladder neck obstruction
Our objective was to assess the effect of the selective α1-blocker alfuzosin on urodynamic parameters and quality of life in… 
Review
2008
Review
2008
Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty
Aims:  Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) are a common problem in ageing men and… 
Highly Cited
2007
Highly Cited
2007
The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract.
Highly Cited
2005
Highly Cited
2005
Clinical Assessment of Drug‐induced QT Prolongation in Association with Heart Rate Changes
2005
2005
Evaluation of Tamsulosin and Alfuzosin Activity in the Rat Vas Deferens: Relevance to Ejaculation Delays
The effect of two α-adrenergic receptor antagonists widely employed in the therapy of benign prostatic hyperplasia, tamsulosin… 
Highly Cited
2004
Highly Cited
2004
A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats
To assess the effects of the α1‐adrenoceptor antagonists alfuzosin and tamsulosin on the physiological events associated with… 
1998
1998
Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice
Objectives: To investigate (a) the magnitude and durability of symptom score reduction and HRQL score improvement (including… 
1997
1997
Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
OBJECTIVE The objective of this double-blind, placebo-controlled urodynamic pressure/flow study was to assess the efficacy of… 
Highly Cited
1993
Highly Cited
1993
Long‐term Treatment of Benign Prostatic Hyperplasia with Alfuzosin: a 12–18 Month Assessment
Summary In order to assess the efficacy and safety of alfuzosin, an alpha-1 blocker, in symptomatic patients with benign… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)